AGRX insider filings
AGILE THERAPEUTICS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-08-26. Screen AGRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AGRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — AGILE THERAPEUTICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-26 | 4 | Gilmore Geoffrey — Chief Administrative Officer | Disposition to issuer (D): 10,125 @ $1.52 · Disposition to issuer (D): 10,131 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Coiante Scott M — Chief Financial Officer | Disposition to issuer (D): 15,000 @ $1.52 · Disposition to issuer (D): 5,080 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Conway Robert G — Chief Supply Chain Officer | Disposition to issuer (D): 10,125 @ $1.52 · Disposition to issuer (D): 3,404 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Korner Paul — Chief Medical Officer | Disposition to issuer (D): 10,125 @ $1.52 · Disposition to issuer (D): 3,375 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Welsh Amy — Chief Commercial Officer | Disposition to issuer (D): 10,125 @ $1.52 · Disposition to issuer (D): 3,375 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Torrente Josephine — Director | Disposition to issuer (D): 13 @ $1.52 · Disposition to issuer (D): 974 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Carson Sandra — Director | Disposition to issuer (D): 973 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | ALTOMARI ALFRED — Chief Executive Officer | Disposition to issuer (D): 28,125 @ $1.52 · Disposition to issuer (D): 19,624 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Fischer Seth H. Z. — Director | Disposition to issuer (D): 976 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | Hubbard John W — Director | Disposition to issuer (D): 976 @ $1.52 | EDGAR |
| 2024-08-26 | 4 | BARBARI SHARON — Director | Disposition to issuer (D): 973 @ $1.52 | EDGAR |
| 2023-10-04 | 4 | Coiante Scott M — Chief Financial Officer | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2023-06-30 | 4 | Welsh Amy — Chief Commercial Officer | Grant/award (A): 13,500 @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | Korner Paul — Chief Medical Officer | Grant/award (A): 13,500 @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Grant/award (A): 37,500 @ $0 · Grant/award (A): 8,963 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | Conway Robert G — Chief Supply Chain Officer | Grant/award (A): 13,500 @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2023-06-30 | 4 | Gilmore Geoffrey — Chief Administrative Officer | Grant/award (A): 13,500 @ $0 · Grant/award (A): 6,716 @ $0 · Grant/award (A): 4,500 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Torrente Josephine — Director | Grant/award (A): 935 @ $0 · Grant/award (A): 1,065 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Fischer Seth H. Z. — Director | Grant/award (A): 935 @ $0 · Grant/award (A): 1,065 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Hubbard John W — Director | Grant/award (A): 935 @ $0 · Grant/award (A): 1,065 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | Carson Sandra — Director | Grant/award (A): 935 @ $0 · Grant/award (A): 1,065 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | BARBARI SHARON — Director | Grant/award (A): 935 @ $0 · Grant/award (A): 1,065 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Welsh Amy — Chief Commercial Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Butch Jason — Principal Accounting Officer | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Korner Paul — Sr. VP and CMO | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Conway Robert G — Chief Supply Chain Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | Gilmore Geoffrey — Chief Administrative Officer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-08-29 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Purchase (P): 50,000 @ $0.45 | EDGAR |
| 2022-06-10 | 4 | Carson Sandra — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Fischer Seth H. Z. — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Hubbard John W — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Shetty Ajit — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Tursi James Patrick — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Torrente Josephine — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | BARBARI SHARON — Director | Grant/award (A): 670 @ $0 · Grant/award (A): 807 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Reilly Dennis — Chief Financial Officer | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Butch Jason — Principal Accounting Officer | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Gilmore Geoffrey — General Counsel | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Grant/award (A): 675,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Korner Paul — Sr. VP and CMO | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2022-01-20 | 4 | Conway Robert G — Chief Supply Chain Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | PERCEPTIVE ADVISORS LLC — 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner EDELMAN JOSEPH — 10% owner | Purchase (P): 5,734,560 @ $0.85 · Purchase (P): 2,687,280 (derivative) | EDGAR |
| 2021-10-14 | 4 | Reilly Dennis — Chief Financial Officer | Purchase (P): 58,824 · Purchase (P): 29,412 (derivative) | EDGAR |
| 2021-10-14 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Purchase (P): 58,824 · Purchase (P): 29,412 (derivative) | EDGAR |
| 2021-10-08 | 4 | Torrente Josephine — Director | Grant/award (A): 79,593 @ $0 · Grant/award (A): 97,116 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | ALTOMARI ALFRED — Chief Executive Officer, Director | Purchase (P): 26,200 @ $1.26 | EDGAR |
| 2021-07-28 | 4 | Reilly Dennis — Chief Financial Officer | Purchase (P): 50,000 @ $1.08 | EDGAR |
| 2021-06-11 | 4 | Carson Sandra — Director | Grant/award (A): 24,510 @ $0 · Grant/award (A): 29,905 (derivative) @ $0 | EDGAR |
| 2021-06-10 | 4 | BARBARI SHARON — Director | Grant/award (A): 24,510 @ $0 · Grant/award (A): 29,905 (derivative) @ $0 | EDGAR |
Recent 8-K events — AGILE THERAPEUTICS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-08-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-16 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-15 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2024-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-09 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AGRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs